Badoux, X. C., Keating, M. J., Wang, X., O'Brien, S. M., Ferrajoli, A., Faderl, S., . . . Wierda, W. G. (2011). Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia. American Society of Hematology.
Chicago Style citaatBadoux, Xavier C., et al. Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab As Salvage Therapy for Heavily Pretreated Patients With Chronic Lymphocytic Leukemia. American Society of Hematology, 2011.
MLA citatieBadoux, Xavier C., et al. Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab As Salvage Therapy for Heavily Pretreated Patients With Chronic Lymphocytic Leukemia. American Society of Hematology, 2011.
Let op: Deze citaties zijn niet altijd 100% accuraat.